-
Why Inovio Fell 27.9% in July
Post on 8/7/20
-
Celldex Provides Corporate Update
Post on 8/6/20
-
Interview with Guy D’Andrea, Founder and Managing Partner of Discern Health
Post on 8/6/20
-
Provention Bio Reports Second Quarter 2020 Financial Results and Provides Business Update
Post on 8/6/20
-
Amneal Reports Second Quarter 2020 Financial Results
Post on 8/6/20
-
Concord Health Partners Announces Investment in Cedar's Series C Funding
Post on 8/6/20
-
Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update
Post on 8/6/20
-
Madrigal Pharmaceuticals Reports 2020 Second Quarter Financial Results and Highlights
Post on 8/6/20
-
Cerecor Reports Second Quarter 2020 Financial Results and Business Update
Post on 8/6/20
-
Tandigm Health Partners with Gateway Medical Associates
Post on 8/5/20
-
OPEN MINDS & NextGen Healthcare Form Platinum Partnership
Post on 8/5/20
-
Citius Pharmaceuticals Announces $6M Bought Deal Offering
Post on 8/5/20
-
Fertility and Pregnancy Test Startup Stix Raised a $1.3M Seed Round
Post on 8/5/20
-
Genesis Biotechnology Group Acquires Comparative Biosciences
Post on 8/5/20
-
AmerisourceBergen Reports Fiscal 2020 Third Quarter Results
Post on 8/5/20
-
Teva Reports Second Quarter 2020 Financial Results
Post on 8/5/20
-
Verrica Pharmaceuticals Reports Second Quarter 2020 Financial Results
Post on 8/5/20
-
Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights
Post on 8/5/20
-
Merck Animal Health Completes Acquisition of IdentiGEN
Post on 8/5/20
-
Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?
Post on 8/5/20
-
Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?
Post on 8/5/20
-
Merck and Hanmi Pharmaceutical Enter into Licensing Agreement
Post on 8/4/20
-
Radiation Business Solutions to Acquire MBR Medical Billing
Post on 8/4/20
-
Spark Therapeutics Recognized for Fourth-straight Year as One of Philadelphia’s “Best Places to Work” by the Philadelphia Business Journal
Post on 8/4/20
-
RespireRx Pharmaceuticals Announces $2 Million Funding Commitment
Post on 8/4/20
Philadelphia
